You just read:

Research and Markets - Nuclear Medicine/Radiopharmaceuticals to Reach $7.27 Billion by 2021 - Key Vendors are Bayer AG, GE Healthcare & IBA Molecular

News provided by

Research and Markets

Nov 25, 2016, 07:10 ET